Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancerPrasad Sanjay Dhiwar, Pujan Sasmal, Ganesh Prasad Shenoy et al.|Medicinal Chemistry Research|2022Cited by 8